Clinical trial
Efficacy and Safety of Calcipotriene/Betamethasone Gel/Ointment in Psoriasis
NCT00279162 · LEO Pharma, Industry · Completed
Key facts
| NCT number | NCT00279162 |
|---|---|
| Title | Efficacy and Safety of Calcipotriene/Betamethasone Gel/Ointment in Psoriasis |
| Official title | Calcipotriene Plus Betamethasone Dipropionate Gel Compared to the Gel Vehicle in Scalp Psoriasis, in Patients Receiving Calcipotriene Plus Betamethasone Dipropionate Ointment for Psoriasis Vulgaris of Trunk/Limbs |
| Lead sponsor | LEO Pharma, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Psoriasis |
| Intervention type | Drug |
| Interventions | Calcipotriene/betamethasone gel and ointment |
| Enrollment | 160 |
| Start date | Dec 1, 2005 |
| Completion | Jul 1, 2007 |
| First posted | Jan 19, 2006 |
| Last update posted | Feb 24, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: